Compare AJANTA PHARMA with WYETH LTD - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA vs WYETH LTD - Comparison Results

WYETH LTD 
   Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AJANTA PHARMA WYETH LTD AJANTA PHARMA/
WYETH LTD
 
P/E (TTM) x 23.5 27.7 84.6% View Chart
P/BV x 4.1 5.3 77.3% View Chart
Dividend Yield % 0.9 1.3 66.9%  

Financials

 AJANTA PHARMA   WYETH LTD
EQUITY SHARE DATA
    AJANTA PHARMA
Mar-19
WYETH LTD
Mar-13
AJANTA PHARMA/
WYETH LTD
5-Yr Chart
Click to enlarge
High Rs1,4221,044 136.1%   
Low Rs898818 109.7%   
Sales per share (Unadj.) Rs233.5298.6 78.2%  
Earnings per share (Unadj.) Rs44.057.2 76.8%  
Cash flow per share (Unadj.) Rs52.258.4 89.3%  
Dividends per share (Unadj.) Rs9.0017.00 52.9%  
Dividend yield (eoy) %0.81.8 42.5%  
Book value per share (Unadj.) Rs255.1249.5 102.2%  
Shares outstanding (eoy) m88.0222.72 387.4%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x5.03.1 159.2%   
Avg P/E ratio x26.416.3 162.2%  
P/CF ratio (eoy) x22.215.9 139.5%  
Price / Book Value ratio x4.53.7 121.8%  
Dividend payout %20.529.7 68.9%   
Avg Mkt Cap Rs m102,08121,157 482.5%   
No. of employees `0006.80.5 1,382.1%   
Total wages/salary Rs m4,307400 1,076.8%   
Avg. sales/employee Rs Th3,022.613,787.4 21.9%   
Avg. wages/employee Rs Th633.4813.0 77.9%   
Avg. net profit/employee Rs Th569.12,643.3 21.5%   
INCOME DATA
Net Sales Rs m20,5546,783 303.0%  
Other income Rs m211353 59.8%   
Total revenues Rs m20,7657,136 291.0%   
Gross profit Rs m5,6641,617 350.2%  
Depreciation Rs m72127 2,709.8%   
Interest Rs m126 210.9%   
Profit before tax Rs m5,1431,938 265.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-5 0.0%   
Tax Rs m1,273632 201.4%   
Profit after tax Rs m3,8701,301 297.6%  
Gross profit margin %27.623.8 115.6%  
Effective tax rate %24.832.6 75.9%   
Net profit margin %18.819.2 98.2%  
BALANCE SHEET DATA
Current assets Rs m11,8126,984 169.1%   
Current liabilities Rs m3,7762,056 183.7%   
Net working cap to sales %39.172.6 53.8%  
Current ratio x3.13.4 92.1%  
Inventory Days Days7799 78.0%  
Debtors Days Days8224 340.8%  
Net fixed assets Rs m14,398244 5,893.7%   
Share capital Rs m175227 77.2%   
"Free" reserves Rs m22,2775,441 409.4%   
Net worth Rs m22,4525,668 396.1%   
Long term debt Rs m725 26.4%   
Total assets Rs m26,9627,901 341.2%  
Interest coverage x444.3353.3 125.8%   
Debt to equity ratio x00 6.7%  
Sales to assets ratio x0.80.9 88.8%   
Return on assets %14.416.5 87.1%  
Return on equity %17.222.9 75.1%  
Return on capital %23.034.0 67.4%  
Exports to sales %00.2 0.0%   
Imports to sales %036.3 0.0%   
Exports (fob) Rs mNA15 0.0%   
Imports (cif) Rs mNA2,465 0.0%   
Fx inflow Rs m10,68215 70,274.3%   
Fx outflow Rs m2,1022,677 78.5%   
Net fx Rs m8,580-2,662 -322.3%   
CASH FLOW
From Operations Rs m3,748923 406.0%  
From Investments Rs m-2,228317 -703.1%  
From Financial Activity Rs m-1,475-481 306.6%  
Net Cashflow Rs m45759 6.0%  

Share Holding

Indian Promoters % 73.8 0.0 -  
Foreign collaborators % 0.0 51.1 -  
Indian inst/Mut Fund % 1.6 11.3 13.7%  
FIIs % 7.6 7.2 105.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.0 30.4 55.9%  
Shareholders   20,968 21,978 95.4%  
Pledged promoter(s) holding % 4.4 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AJANTA PHARMA With:   DR. DATSONS LABS  STRIDES PHARMA SCIENCE  TTK HEALTHCARE  JUBILANT LIFE SCIENCES  BIOCON   

Compare AJANTA PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Strengthening Rupee, Inflation & Factory Output Data, and Top Stocks in Action Today(Pre-Open)

On Friday, Indian share markets witnessed most of the buying interest during closing hours and ended on a strong note.

Related Views on News

AJANTA PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 8.4% (Quarterly Result Update)

Aug 2, 2019 | Updated on Aug 2, 2019

For the quarter ended June 2019, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 8.4% YoY). Sales on the other hand came in at Rs 6 bn (up 19.8% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 24, 2019 | Updated on Jun 24, 2019

Here's an analysis of the annual report of AJANTA PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of AJANTA PHARMA. Also includes updates on the valuation of AJANTA PHARMA.

AJANTA PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 5.9% (Quarterly Result Update)

May 3, 2019 | Updated on May 3, 2019

For the quarter ended March 2019, AJANTA PHARMA has posted a net profit of Rs 889 m (down 5.9% YoY). Sales on the other hand came in at Rs 5 bn (down 2.9% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (3QFY19); Net Profit Down 54.6% (Quarterly Result Update)

Feb 1, 2019 | Updated on Feb 1, 2019

For the quarter ended December 2018, AJANTA PHARMA has posted a net profit of Rs 669 m (down 54.6% YoY). Sales on the other hand came in at Rs 5 bn (down 17.4% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (2QFY19); Net Profit Down 4.9% (Quarterly Result Update)

Nov 6, 2018 | Updated on Nov 6, 2018

For the quarter ended September 2018, AJANTA PHARMA has posted a net profit of Rs 1 bn (down 4.9% YoY). Sales on the other hand came in at Rs 5 bn (up 0.7% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

More Views on News

Most Popular

Buying these Eight Stocks is Like Owning Your Own Business(Profit Hunter)

Sep 5, 2019

Everyone dreams of owning a business. Here is your chance.

7 Stocks to Buy in the Market Today(The 5 Minute Wrapup)

Sep 5, 2019

The stock market had a four-year bull run starting September 2013. Are we seeing a similar pattern now?

Don't Buy Lakshmi Vilas Bank...Buy this Private Sector Bank with 74% Upside(The 5 Minute Wrapup)

Sep 4, 2019

Lakshmi Vilas Bank is in a vicious cycle. The stock is already down 57% in 2019. Despite this, the retail investors increased their holding.

Insider Buying Alert: Promoters Increase Stake in 8 High-Quality Smallcaps(Profit Hunter)

Sep 3, 2019

Insiders have increased their stakes in eight Hidden Treasure recommendations. Should you follow them?

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

AJANTA PHARMA SHARE PRICE


Sep 13, 2019 (Close)

TRACK AJANTA PHARMA

  • Track your investment in AJANTA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AJANTA PHARMA - UNICHEM LAB COMPARISON

COMPARE AJANTA PHARMA WITH

MARKET STATS